Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Shareholders' Equity (Unaudited)

v3.20.1
Condensed Consolidated Statement of Changes in Shareholders' Equity (Unaudited) - USD ($)
Series D Convertible Preferred Stock [Member]
Common Stock [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income/(Loss) [Member]
Total
Balance at Dec. 31, 2018 $ 121,554,547 $ (115,694,881) $ (25,913) $ 5,833,753
Balance, shares at Dec. 31, 2018 540,607      
Net loss     (916,958)   (916,958)
Issuance of stock grants to key employees $ 15,874 15,874
Issuance of stock grants to key employees, shares 625      
Share-based compensation - Directors - restricted stock units $ 3,906 3,906
Net unrealized (gain) loss on marketable securities       29,343 29,343
Balance at Mar. 31, 2019 $ 121,574,327 (116,611,839) 3,430 4,965,918
Balance, shares at Mar. 31, 2019 541,232      
Balance at Dec. 31, 2018 $ 121,554,547 (115,694,881) (25,913) 5,833,753
Balance, shares at Dec. 31, 2018 540,607      
Net loss         (3,888,249)
Balance at Dec. 31, 2019 $ 128,920,414 (119,583,130) 17,886 9,355,170
Balance, shares at Dec. 31, 2019 1,738,837      
Net loss     (3,538,536)   (3,538,536)
Share-based compensation - Directors - restricted stock units   $ 1,302 1,302
Exercise of prepaid equity forward contracts for common stock $ 77 77
Exercise of prepaid equity forward contracts for common stock, shares 765,000      
Shares issued for the purchase of license $ 418,479 $ 814,578 1,233,057
Shares issued for the purchase of license, shares 211,353 411,403      
Stock-based compensation - shares issued to vendors   $ 7,318 7,318
Net unrealized (gain) loss on marketable securities       (240,937) (240,937)
Balance at Mar. 31, 2020 $ 418,479 $ 129,743,689 $ (123,121,666) $ (223,051) $ 6,817,451
Balance, shares at Mar. 31, 2020 211,353 2,915,240